Systema Nova

Systema Nova is a London-based venture capital firm investing in early-stage AI and deep-tech startups, with a particular focus on climate, fintech and healthtech. Registered at 100 Cannon Street, London, the firm is authorised and regulated by the UK Financial Conduct Authority. It backs companies at the pre-seed and seed stages, writing typical cheques in the range of roughly EUR 100k to EUR 1.5M, generally as a co-investor. Systema Nova emphasises a hands-on model that provides growth acceleration through a network of go-to-market experts and strategic support to help founders enter and scale in new markets. Its investment areas span healthtech, deeptech, artificial intelligence and sustainability. Portfolio companies include Solence, a healthcare venture that has raised about $2.1M; HyveGeo, which develops microalgae-based solutions for carbon removal and sustainable agriculture; and Diesta, a payments and reconciliation platform for the insurance industry that has raised about $5.85M alongside co-investors such as Restive Ventures, SixThirty, Westerly and Antler. The firm is led by founder and CEO Stephane Mardel and General Partner Farid Haque. It is a distinct entity from Sistema Venture Capital, the Moscow-based corporate venture arm of Sistema. By combining FCA-regulated structure, early-stage focus and operational go-to-market support, Systema Nova backs founders building AI and deep-tech solutions for climate, financial-services and healthcare challenges across Europe.